back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-18 18:36 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,518
+1,700 vol $10.89 each |
337,910 | |
| Filed 2026-03-18 18:35 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,638
+1,800 vol $10.91 each |
336,210 | |
| Filed 2026-03-18 18:35 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,352
+400 vol $10.88 each |
334,410 | |
| Filed 2026-03-18 18:34 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,026
+1,929 vol $10.90 each |
38,702 | |
| Filed 2026-03-18 18:33 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,084
+1,300 vol $10.83 each |
36,773 | |
| Filed 2026-03-18 18:31 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,168
+1,800 vol $10.65 each |
36,945 | |
| Filed 2026-03-18 18:30 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Benjamin Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,385
+3,874 vol $10.17 each |
37,019 | |
| Filed 2026-03-18 18:28 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,003
+4,200 vol $10.71 each |
11,237 | |
| Filed 2026-03-18 18:23 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,533
+1,700 vol $10.90 each |
1,632,470 | |
| Filed 2026-03-02 16:30 Tx date 2026-03-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Benjamin Freedman (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$60,000
+20,000 vol $3.00 each |
33,145 | |
| Filed 2026-03-02 16:28 Tx date 2026-03-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$450,000
+150,000 vol $3.00 each |
387,300 | |
| Filed 2026-03-02 16:26 Tx date 2026-03-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-510,000
-170,000 vol $3.00 each |
0 | |
| Filed 2026-02-21 14:03 Tx date 2026-02-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: RRSP (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$67,484
+7,037 vol $9.59 each |
7,037 | |
| Filed 2026-02-21 14:01 Tx date 2026-02-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: RRSP (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$60,447
+7,037 vol $8.59 each |
||
| Filed 2026-02-21 13:54 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: RRSP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-02-21 13:52 Tx date 2026-02-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$42,991
+4,483 vol $9.59 each |
334,010 | |
| Filed 2026-02-21 13:50 Tx date 2026-02-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,000,006
+142,858 vol $7.00 each |
1,630,770 | |
| Filed 2026-02-21 13:49 Tx date 2026-02-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,204,714
+125,622 vol $9.59 each |
1,487,912 | |
| Filed 2025-12-22 18:43 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
10,000 | |
| Filed 2025-12-22 18:39 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-22 18:39 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Units Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
||
| Filed 2025-12-19 19:49 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Units Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
||
| Filed 2025-12-19 19:52 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$172,600
+20,000 vol $8.63 each |
155,000 | |
| Filed 2025-12-19 19:50 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
$172,600
+20,000 vol $8.63 each |
||
| Filed 2025-12-19 19:49 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Units Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
10,000 | |
| Filed 2025-12-19 19:48 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Units Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-26 17:41 Tx date 2025-09-26 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+1,500 vol |
329,527 | |
| Filed 2025-09-26 17:38 Tx date 2025-09-26 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-1,500 vol |
1,362,290 | |
| Filed 2025-09-26 16:16 Tx date 2025-09-26 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
-3,500 vol |
35,473 | |
| Filed 2025-09-24 17:34 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$36,151
+6,573 vol $5.50 each |
38,973 | |
| Filed 2025-09-24 17:31 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Benjamin Freedman (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$72,297
+13,145 vol $5.50 each |
13,145 | |
| Filed 2025-09-24 17:30 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Benjamin Freedman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-24 17:29 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$72,297
+13,145 vol $5.50 each |
||
| Filed 2025-09-24 17:29 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$72,297
+13,145 vol $5.50 each |
35,145 | |
| Filed 2025-09-24 17:28 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,554,448
+282,627 vol $5.50 each |
328,027 | |
| Filed 2025-09-24 17:26 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman-Feinstein Family Foundation (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$337,425
+61,350 vol $5.50 each |
61,350 | |
| Filed 2025-09-24 17:25 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman-Feinstein Family Foundation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-24 17:20 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$914,595
+166,290 vol $5.50 each |
1,363,790 | |
| Filed 2025-06-19 12:42 Tx date 2025-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,705
+5,000 vol $5.94 each |
1,197,500 | |
| Filed 2025-06-19 12:40 Tx date 2025-06-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,410
+5,000 vol $5.68 each |
1,192,500 | |
| Filed 2025-06-19 12:37 Tx date 2025-06-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,250
+5,000 vol $5.45 each |
45,400 | |
| Filed 2025-06-19 12:36 Tx date 2025-06-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,735
+5,000 vol $5.35 each |
40,400 | |
| Filed 2025-06-19 12:35 Tx date 2025-06-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,690
+5,000 vol $5.34 each |
35,400 | |
| Filed 2025-06-19 12:34 Tx date 2025-06-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,585
+5,000 vol $5.32 each |
30,400 | |
| Filed 2025-06-19 12:33 Tx date 2025-06-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,400
+1,400 vol $5.29 each |
25,400 | |
| Filed 2025-06-19 12:31 Tx date 2025-06-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,560
+2,000 vol $5.28 each |
32,400 | |
| Filed 2025-06-09 14:26 Tx date 2025-06-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Convertible Preferred Shares Series 1
10 - Acquisition or disposition in the public market
|
$-100,000
-20,000 vol $5.00 each |
1,493,985 | |
| Filed 2025-06-05 15:34 Tx date 2015-01-14 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Voting Shares
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2025-03-27 13:40 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,300
+45,000 vol $5.14 each |
135,000 | |
| Filed 2025-01-04 16:21 Tx date 2024-12-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$419,400
+90,000 vol $4.66 each |
90,000 | |
| Filed 2025-01-04 16:16 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-12 19:41 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Convertible Preferred Shares Series 1
00 - Opening Balance-Initial SEDI Report
|
460,000 | ||
| Filed 2024-11-12 19:40 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Convertible Preferred Shares Series 1
00 - Opening Balance-Initial SEDI Report
|
1,200,000 | ||
| Filed 2024-11-12 19:39 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Convertible Preferred Shares Series 1
00 - Opening Balance-Initial SEDI Report
|
1,513,985 | ||
| Filed 2024-11-10 20:20 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
170,000 | ||
| Filed 2024-11-10 20:14 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
237,300 | ||
| Filed 2024-11-10 20:13 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
24,000 | ||
| Filed 2024-11-10 20:12 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,000 | ||
| Filed 2024-11-10 20:10 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
30,400 | ||
| Filed 2024-11-10 20:04 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,187,500 | ||
| Filed 2024-11-08 14:12 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-08 14:12 Tx date 2024-10-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,006,100 | ||
| Filed 2022-08-11 12:56 Tx date 2022-08-10 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Voting Shares
10 - Acquisition or disposition in the public market
|
$268,600
+20,000 vol $13.43 each |
40,000 | |
| Filed 2020-05-25 10:34 Tx date 2020-05-25 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Voting Shares
10 - Acquisition or disposition in the public market
|
$18,000
+2,000 vol $9.00 each |
20,000 | |
| Filed 2020-05-25 10:34 Tx date 2020-05-22 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Voting Shares
10 - Acquisition or disposition in the public market
|
$36,500
+4,000 vol $9.13 each |
18,000 | |
| Filed 2020-05-25 10:32 Tx date 2020-05-21 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Voting Shares
10 - Acquisition or disposition in the public market
|
$73,675
+8,000 vol $9.21 each |
14,000 | |
| Filed 2020-05-25 10:01 Tx date 2020-05-19 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Voting Shares
10 - Acquisition or disposition in the public market
|
$53,610
+6,000 vol $8.94 each |
6,000 | |
| Filed 2020-05-25 09:58 Tx date 2010-12-31 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-27 Tx date 2016-06-20 |
$
Brookfield Business Partners L.P. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Direct Ownership
|
Limited Partnership Units
00 - Opening Balance-Initial SEDI Report
|
36,009 | ||
| Filed 2016-06-27 Tx date 2016-06-20 |
$
Brookfield Business Partners L.P. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: Spouse RRSP (Indirect Ownership)
|
Limited Partnership Units
00 - Opening Balance-Initial SEDI Report
|
30 | ||
| Filed 2016-06-27 Tx date 2016-06-20 |
$
Brookfield Business Partners L.P. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Limited Partnership Units
00 - Opening Balance-Initial SEDI Report
|
6 | ||
| Filed 2016-06-27 Tx date 2016-06-20 |
$
Brookfield Business Partners L.P. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Limited Partnership Units
00 - Opening Balance-Initial SEDI Report
|
9 | ||
| Filed 2015-11-20 Tx date 2015-11-18 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A Limited Voting
47 - Acquisition or disposition by gift
|
$-58,647.55
-1,300 vol $45.11 each |
0 | |
| Filed 2015-11-20 Tx date 2015-11-18 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,296.71
-1,300 vol $11.77 each |
598,700 | |
| Filed 2015-11-20 Tx date 2015-11-18 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A Limited Voting
51 - Exercise of options
|
$15,296
+1,300 vol $11.77 each |
1,300 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: Partners Ltd. (Indirect Ownership)
|
Common Shares Class A Limited Voting
35 - Stock dividend
|
+38,913 vol |
116,740 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Shares
35 - Stock dividend
|
+48,541 vol |
145,624 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Direct Ownership
|
Options
35 - Stock dividend
|
+200,000 vol |
600,000 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
35 - Stock dividend
|
+63,565 vol |
190,695 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: Spouse RRSP (Indirect Ownership)
|
Common Shares Class A Limited Voting
35 - Stock dividend
|
+500 vol |
1,500 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares Class A Limited Voting
35 - Stock dividend
|
+150 vol |
450 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: RESP (Indirect Ownership)
|
Common Shares Class A Limited Voting
35 - Stock dividend
|
+100 vol |
300 | |
| Filed 2015-08-28 Tx date 2015-05-12 |
$BAM
Brookfield Asset Management Inc. |
Freedman, Joseph Stuart
5 - Senior Officer of Issuer
Holder: BAM Holdings Corp. (Indirect Ownership)
|
Common Shares Class A Limited Voting
35 - Stock dividend
|
+425,000 vol |
1,275,000 |